BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6247642)

  • 1. On the mechanism of action of the phagocytosis-stimulating peptide tuftsin.
    Stabinsky Y; Bar-Shavit Z; Fridkin M; Goldman R
    Mol Cell Biochem; 1980 Apr; 30(2):71-7. PubMed ID: 6247642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
    Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
    Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tuftsin alter phagocytosis by human polymorphonuclear neutrophils?
    Cooper MR; DeChatelet LR; Shirley PS; Cooper MR
    Inflammation; 1982 Mar; 6(1):103-12. PubMed ID: 6896319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuftsin and some analogs: synthesis and interaction with human polymorphonuclear leukocytes.
    Fridkin M; Stabinsky Y; Zakuth V; Spirer Z
    Biochim Biophys Acta; 1977 Jan; 496(1):203-11. PubMed ID: 576412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors.
    Goldman R; Bar-Shavit Z
    Ann N Y Acad Sci; 1983; 419():143-55. PubMed ID: 6201115
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuftsin and substance P as modulators of phagocyte functions.
    Bar-Shavit Z; Goldman R
    Adv Exp Med Biol; 1982; 141():549-58. PubMed ID: 6178274
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity relationship of tuftsin, a phagocytosis-stimulating peptide, and its analogs.
    Hisatsune K; Kobayashi K; Nozaki S; Muramatsu I
    Chem Pharm Bull (Tokyo); 1978 Mar; 26(3):1006-7. PubMed ID: 580599
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of human granulocyte phagocytosis stimulation by tuftsin.
    Nishioka K; Wagle JR; Rodriguez T; Maeta M; Kubo S; Dessens SE
    J Surg Res; 1994 Jan; 56(1):94-101. PubMed ID: 8277776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide fragments from the tuftsin containing domain of immunoglobulin G synthesis and biological activity.
    Gottlieb P; Tzehoval E; Feldman M; Segal S; Fridkin M
    Biochem Biophys Res Commun; 1983 Aug; 115(1):193-200. PubMed ID: 6311202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis-stimulating activity of tuftsin analogs.
    Hisatsune K; Kobayashi K; Nozaki S; Muramatsu I
    Microbiol Immunol; 1978; 22(9):581-4. PubMed ID: 581603
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-related changes in cAMP and cGMP levels during phagocytosis in human polymorphonuclear leukocytes.
    Fülöp T; Fóris G; Leövey A
    Mech Ageing Dev; 1984 Oct; 27(2):233-7. PubMed ID: 6092792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phagocytosis stimulating peptide tuftsin: further look into structure-function relationships.
    Stabinsky Y; Gottlieb P; Fridkin M
    Mol Cell Biochem; 1980 May; 30(3):165-70. PubMed ID: 6893216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoassay of the phagocytosis-stimulating peptide tuftsin in normal and splenectomized subjects.
    Spirer Z; Zakuth V; Bogair N; Fridkin M
    Eur J Immunol; 1977 Feb; 7(2):69-74. PubMed ID: 577481
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytes.
    Stabinsky Y; Gottlieb P; Zakuth V; Spirer Z; Fridkin M
    Biochem Biophys Res Commun; 1978 Jul; 83(2):599-606. PubMed ID: 581265
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition by tuftsin of Rauscher virus leukemia development in mice.
    Knyszynski A; Gottlieb P; Fridkin M
    J Natl Cancer Inst; 1983 Jul; 71(1):87-90. PubMed ID: 6575215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.